Board of directors

MSc in Finance from the Stockholm School of Economics and University Medical studies at Linköping University.

CEO of Fidelio Capital AB, Fidelio Capital II AB and Fidelio Capital I AB. Chairman and/or board member of a number of companies within the Fidelio Capital II AB-group. Board member of Bellbox Holding AB and Pencey Holding AB.

CEO of Fidelio Capital, Investment Manager at Nordic Capital and Associate at Carnegie Investment Bank.

Gabriel is an ultimate beneficial owner of Fidelio Vet Holding AB, the Principal Owner of the Company.

The Company and executive management: Yes
Major shareholders: No

PhD in tumor immunology and M.D. from the University of Lund and visiting professor at Lund University, Medical Faculty.

Board member of Agilent Technologies.

Chief Scientific Officer and President, Worldwide Research, Development and Medical at Pfizer, President of Worldwide R&D at Pfizer, President and Head of R&D at Wyeth Pharmaceuticals, Executive Vice President and Head of Pharmaceutical Research at Boehringer Ingelheim, Global VP at AstraZeneca.

0 ordinary shares, 0 C shares.
Subscribed for a total of 31,354 warrants in the Company under Board LTI 2021.

The Company and executive management: Yes
Major shareholders: Yes

Bachelor’s degree in Economics from Trier University and MBA from Clark University, USA.

Member of the Supervisory Board at SHL-Medical, Zug. Member of the Supervisory Board, Chair of the ESG Task Force and member of the Technology Committee at Straumann Group. Member of the Supervisory Board and Chair of the Digital Advisory Board at VZUG, Zug. Member of the Advisory Board at Lima Corporate.

Member of the Executive Management Board and Global Head Dental Service Organizations at Straumann Group. Member of the Executive Committee of Nobel Biocare. Several years of experience in life science companies, the high-tech sector and over ten years of experience as a board member in companies within the MedTech industry.

40,000 ordinary shares, 0 C shares.

The Company and executive management: Yes.
Major shareholders: Yes.

MSc in Finance and Business Administration from Stockholm School of Economics and a CEMS Master in International Management from Bocconi University in Milan.

Board member of Ework Group AB, Billogram AB, Trollheim Studios AB and Grebretsew AB. Deputy board member of Namrega AB.

Group CEO of Allurity, CEO of IP-Only, deputy CEO and COO of SF Studios, various roles within the Bonnier Group and Associate at Goldman Sachs.

6,500 ordinary shares, 0 C shares.
Subscribed for a total of 20,903 warrants in the Company under Board LTI 2021.

The Company and executive management: Yes
Major shareholders: Yes

B.Sc. Business Administration and Economics from Stockholm University.

CFO Polarium Energy Solutions AB and Board member of Storskogen Group AB.

CFO and EVP Hexagon AB. Group Treasurer Hexagon AB, Group Treasurer EF Education First Ltd, Assistant Group Treasurer Autoliv Inc, Chief Dealer Esselte AB.

0 ordinary shares, 0 C shares.

The Company and executive management: Yes.
Major shareholders: Yes.

MSc in Finance from the Stockholm School of Economics.

Chairman and/or board member of a number of companies within the Fidelio Capital II AB-group. Deputy board member of Greenfood AB (publ) and Greenfood MC AB

Partner at Fidelio Capital, Investment Manager at Nordic Capital and Analyst at Goldman Sachs.

0 ordinary shares, 0 C shares.
0 warrants.

The Company and executive management: Yes
Major shareholders: No

BSc in Finance and Marketing from the Stockholm School of Economics.

Deputy CEO of Fidelio Capital AB, Fidelio Capital II AB and Fidelio Capital I AB. Board member of a number of companies within the Fidelio Capital II AB-group, TBON Invest AB and Bellbox Holding AB. Deputy board member of a number of companies within the Fidelio Capital AB-group, a number of companies within the Fidelio Capital II AB-group, Auxo AB, WF Simhold AB, Bisslinge Finans AB, Southern Meadow AB and Berghamnen AB.

Director at Fidelio Capital.

0 ordinary shares, 0 C shares.
0 warrants.

The Company and executive management: Yes
Major shareholders: No